Urologie Bethanien is a clinic specialising in fusion biopsy as part of prostate cancer screening. The Artemis system offers significant benefits here as it enables robot-assisted, high-precision tissue removal. Artemis can accurately locate even the smallest suspect areas, therefore enabling more precise diagnosis and more targeted treatment.
Vital cancer screening for men
Prostate cancer is the most common malignant tumour in men over 50 years of age. Prostate cancer even amounts to 27% of all cancers. In Switzerland, this affects around 6000 men every year. The disease is terminal in almost one in four cases. In light of this, it is all the more important to detect incipient prostate cancer at an early stage. This significantly increases chances of healing.
Early detection and diagnosis
For early detection of prostate cancer, all relevant guidelines (AUA, EAU, DGU, SGU) recommend the same thing: men of around 50 years of age and above should have their PSA value checked and their prostate palpated. In Switzerland this is usually done by their GP. If any abnormalities are discovered, they are then referred to the urologist.
If the patient comes to us, we perform an ultrasound examination and then discuss the further clarifications with them. If a biopsy (tissue removal) is required, we first register the patient for a prostate MRI, which we carry out here at the Bethanien clinic. The clinic has the very latest equipment and – more importantly – highly experienced radiologists to perform screening. If there are any abnormalities, they can use special software to precisely mark the suspect areas. Shortly after this, we have the whole data set for assessment.
How does Artemis fusion biopsy work?
After consulting the MRI images, we then plan the biopsy and decide together with the patient if they would prefer a transrectal biopsy with local anaesthetic or a transperineal biopsy with a short anaesthesia. To protect against infection, the patient takes a short course of antibiotics beforehand. The clear benefits of the Artemis system are shown in the fusion biopsy carried out in the next stage. During tissue removal, the 3D ultrasound images can be merged with the 3D MRI images. This means that they can be directly overlaid like a template. This enables tissue to be removed from the abnormal areas with a high degree of accuracy. After this, the tissue samples removed are embedded, cut, dyed and examined under the microscope for any prostate cancer by a pathologist. Just a few days later, we then have the results and can discuss them with the patient.
Advantages for cancer treatment
If surgery is required, the higher level of precision in locating tumours enables improved planning and more gentle treatment. However, not all prostate cancer requires surgery. Under certain circumstances, regular observation will be sufficient. This in turn requires a high level of experience from the urologists, radiologists and pathologists involved and extremely precise biopsy technology in the form of the Artemis system.
For questions and personal consultation, please feel free to contact us by telephone or email:
+41 43 268 29 29
About the specialist
Specialist for urology and surgery, member of the Swiss Medical Association, FMH